174 related articles for article (PubMed ID: 25358915)
1. Benidipine suppresses in situ proliferation of leukocytes and slows the progression of renal fibrosis in rat kidneys with advanced chronic renal failure.
Kazama I; Baba A; Matsubara M; Endo Y; Toyama H; Ejima Y
Nephron Exp Nephrol; 2014; 128(1-2):67-79. PubMed ID: 25358915
[TBL] [Abstract][Full Text] [Related]
2. Less contribution of mast cells to the progression of renal fibrosis in Rat kidneys with chronic renal failure.
Baba A; Tachi M; Ejima Y; Endo Y; Toyama H; Saito K; Abe N; Yamauchi M; Miura C; Kazama I
Nephrology (Carlton); 2017 Feb; 22(2):159-167. PubMed ID: 26840502
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of Delayed Rectifier K(+) Channels Promotes In situ Proliferation of Leukocytes in Rat Kidneys with Advanced Chronic Renal Failure.
Kazama I; Maruyama Y; Endo Y; Toyama H; Ejima Y; Matsubara M; Kurosawa S
Int J Nephrol; 2012; 2012():581581. PubMed ID: 22701172
[TBL] [Abstract][Full Text] [Related]
4. Benidipine, a long-acting calcium-channel blocker, prevents the progression to end-stage renal failure in a rat mesangioproliferative glomerulonephritis.
Nakamura T; Obata JE; Onitsuka M; Shimada Y; Yoshida Y; Kawachi H; Shimizu F
Nephron; 2000 Nov; 86(3):315-26. PubMed ID: 11096289
[TBL] [Abstract][Full Text] [Related]
5. Delayed Rectifier K
Abe N; Toyama H; Saito K; Ejima Y; Yamauchi M; Mushiake H; Kazama I
Biomed Res Int; 2019; 2019():7567638. PubMed ID: 31828127
[TBL] [Abstract][Full Text] [Related]
6. Benidipine persistently inhibits delayed rectifier K(+)-channel currents in murine thymocytes.
Kazama I; Maruyama Y; Matsubara M
Immunopharmacol Immunotoxicol; 2013 Feb; 35(1):28-33. PubMed ID: 22978806
[TBL] [Abstract][Full Text] [Related]
7. Physiological significance of delayed rectifier K(+) channels (Kv1.3) expressed in T lymphocytes and their pathological significance in chronic kidney disease.
Kazama I
J Physiol Sci; 2015 Jan; 65(1):25-35. PubMed ID: 25096892
[TBL] [Abstract][Full Text] [Related]
8. Roles of lymphocyte kv1.3-channels in the pathogenesis of renal diseases and novel therapeutic implications of targeting the channels.
Kazama I
Mediators Inflamm; 2015; 2015():436572. PubMed ID: 25866450
[TBL] [Abstract][Full Text] [Related]
9. Benidipine inhibits apoptosis during ischaemic acute renal failure in rats.
Yao K; Sato H; Ina Y; Nagashima K; Nishikawa S; Ohmori K; Ohno T
J Pharm Pharmacol; 2000 May; 52(5):561-8. PubMed ID: 10864145
[TBL] [Abstract][Full Text] [Related]
10. Benidipine, a dihydropyridine L-type/T-type calcium channel blocker, affords additive benefits for prevention of cardiorenal injury in hypertensive rats.
Yamamoto E; Kataoka K; Dong YF; Nakamura T; Fukuda M; Nako H; Ogawa H; Kim-Mitsuyama S
J Hypertens; 2010 Jun; 28(6):1321-9. PubMed ID: 20224431
[TBL] [Abstract][Full Text] [Related]
11. Benidipine, an anti-hypertensive drug, inhibits reactive oxygen species production in polymorphonuclear leukocytes and oxidative stress in salt-loaded stroke-prone spontaneously hypertensive rats.
Matsubara M; Akizuki O; Ikeda J; Saeki K; Yao K; Sasaki K
Eur J Pharmacol; 2008 Feb; 580(1-2):201-13. PubMed ID: 18048030
[TBL] [Abstract][Full Text] [Related]
12. Effects of the AT(1) receptor blocker losartan and the calcium channel blocker benidipine on the accumulation of lipids in the kidney of a rat model of metabolic syndrome.
Ishizaka N; Hongo M; Matsuzaki G; Furuta K; Saito K; Sakurai R; Sakamoto A; Koike K; Nagai R
Hypertens Res; 2010 Mar; 33(3):263-8. PubMed ID: 20057486
[TBL] [Abstract][Full Text] [Related]
13. Involvement of N-type Ca(2+) channels in the fibrotic process of the kidney in rats.
Mishima K; Maeshima A; Miya M; Sakurai N; Ikeuchi H; Hiromura K; Nojima Y
Am J Physiol Renal Physiol; 2013 Mar; 304(6):F665-73. PubMed ID: 23324177
[TBL] [Abstract][Full Text] [Related]
14. Blockade of T-type voltage-dependent Ca2+ channels by benidipine, a dihydropyridine calcium channel blocker, inhibits aldosterone production in human adrenocortical cell line NCI-H295R.
Akizuki O; Inayoshi A; Kitayama T; Yao K; Shirakura S; Sasaki K; Kusaka H; Matsubara M
Eur J Pharmacol; 2008 Apr; 584(2-3):424-34. PubMed ID: 18331727
[TBL] [Abstract][Full Text] [Related]
15. Effects of calcium antagonist, benidipine, on the progression of chronic renal failure in the elderly: a 1-year follow-up.
Suzuki H; Saruta T;
Clin Exp Hypertens; 2001 Apr; 23(3):189-201. PubMed ID: 11339686
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the antiproteinuric effects of the calcium channel blockers benidipine and amlodipine administered in combination with angiotensin receptor blockers to hypertensive patients with stage 3-5 chronic kidney disease.
Abe M; Okada K; Maruyama T; Maruyama N; Matsumoto K
Hypertens Res; 2009 Apr; 32(4):270-5. PubMed ID: 19262495
[TBL] [Abstract][Full Text] [Related]
17. Mast cell involvement in the progression of peritoneal fibrosis in rats with chronic renal failure.
Kazama I; Baba A; Endo Y; Toyama H; Ejima Y; Matsubara M; Tachi M
Nephrology (Carlton); 2015 Sep; 20(9):609-16. PubMed ID: 25881494
[TBL] [Abstract][Full Text] [Related]
18. Benidipine, a long-acting calcium channel blocker, inhibits cardiac remodeling in pressure-overloaded mice.
Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Asanuma H; Minamino T; Tomoike H; Hori M; Kitakaze M
Cardiovasc Res; 2005 Mar; 65(4):879-88. PubMed ID: 15721868
[TBL] [Abstract][Full Text] [Related]
19. Effect of a serine protease inhibitor on the progression of chronic renal failure.
Hayata M; Kakizoe Y; Uchimura K; Morinaga J; Yamazoe R; Mizumoto T; Onoue T; Ueda M; Shiraishi N; Adachi M; Miyoshi T; Sakai Y; Tomita K; Kitamura K
Am J Physiol Renal Physiol; 2012 Oct; 303(8):F1126-35. PubMed ID: 22832926
[TBL] [Abstract][Full Text] [Related]
20. Beneficial effects of low-dose benidipine in acute autoimmune myocarditis: suppressive effects on inflammatory cytokines and inducible nitric oxide synthase.
Yuan Z; Kishimoto C; Shioji K
Circ J; 2003 Jun; 67(6):545-50. PubMed ID: 12808275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
